Date Title Description PDF
26 Jun 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives Download
24 Jun 2024 On business and financial situation ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth Download
08 May 2024 On P&L The Company releases the first three months 2024 financial results presentation Download
08 May 2024 On P&L The Company releases the press release related to the first three months of 2024 financial results Download
25 Apr 2024 On business and financial situation ROVI announces agreement to manufacture pre-filled syringes Download

Pages

Date Title Description PDF
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download
07 Oct 2021 Liquidity and counterparty agreements Download
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download

Pages

Date Title Description PDF
17 Mar 2016 Acuerdos estratégicos con terceros Enervit Nutrition, joint venture of ROVI and Enervit, will distribute nutritional products in Spain and Portugal Download
24 Feb 2016 Información sobre resultados (2) ROVI releases the press release related to the full year 2015 results Download
24 Feb 2016 Información sobre resultados ROVI releases the press release related to the full year 2015 results Download
24 Feb 2016 Contratos de liquidez y contrapartida The Company informs that it has signed a liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
24 Feb 2016 Informe Anual de Gobierno Corporativo 2015 ROVI releases the 2015 Annual Corporate Governance Report Download

Pages